^
Association details:
Biomarker:No biomarker
Cancer:Pancreatic Adenocarcinoma
Regimen:OFF
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
05/04/2023
Excerpt:
Pancreatic Adenocarcinoma….PRINCIPLES OF SYSTEMIC THERAPY….Intermediate PS2….Other Recommended Regimens...OFF (category 2B)